SCHEMBL6155430

SCHEMBL6155430

Cc1csc(C(=O)NNC(=S)Nc2ccc(Cl)c(Cl)c2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.57
ALDH1A1 P00352 7/20 0.57
GAA P10253 6/20 0.57
MEN1 O00255 5/20 0.57
KMT2A Q03164 5/20 0.57
RAB9A P51151 4/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
HKDC1 Q2TB90 1/20 0.57
IDO1 P14902 2/20 0.55
PLA2G10 O15496 1/20 0.55
PHGDH O43175 1/20 0.55
F2 P00734 1/20 0.55
CA2 P00918 1/20 0.55
PLA2G1B P04054 1/20 0.55
ARG1 P05089 1/20 0.55
LCK P06239 1/20 0.55
HTR1A P08908 1/20 0.55
CHRM1 P11229 1/20 0.55
ACE P12821 1/20 0.55
PLA2G2A P14555 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6155423 0.72 CA2 (0.56) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL6154935 0.70 GAA (0.67) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL4555003 0.70 IDO1 (0.78) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL6815301 0.68 ALDH1A1 (0.65) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL11887815 0.68 EPHX1 (0.68) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL10660750 0.67 IDO1 (0.68) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL14120200 0.67 MAPT (1.00) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL9348874 0.67 MAPT (0.55) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL19260918 0.67 MAPT (0.54) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL29410073 0.67 MAPT (0.54) MAPTALDH1A1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP MAPT 3318/4885ALDH1A1 961/4885GAA 2365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.